News

Lawyers and Pandemic Response: How the Joint Assisted Acquisition (JA2) Legal Cell Joined the Fight Against COVID-19
April 18, 2023 — President Biden announced that in May 2023, the U.S. will officially end its emergency response posture to the COVID-19 pandemic. This announcement marks a significant milestone in a long and difficult journey. From masks, to at-home test kits, to vaccines, countless experts worked tirelessly behind the scenes to develop the products and solutions... MORE

Ten people in business attire stand in front of flags and hold certificates of appreciation and award for service.

Medical Countermeasure Autoinjector Summit Held to Promote Performer and Joint Force Alignment
March 21, 2023 — On January 26, the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense’s (JPEO-CBRND) Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical) team hosted an autoinjector-focused summit, held at the Defense Health Agency Headquarters in Falls Church, Virginia.With the... MORE

COL Clark speaking at a podium in front of a group of a seated audience

Mobile Chem-Bio Detection Lab Now Fielded in all 50 States, Territories
February 15, 2023 — The mobile laboratory used for detecting and identifying chemical and biological hazards has now been delivered to all National Guard Bureau’s Weapons of Mass Destruction - Civil Support Teams (CST) in all 50 U.S. states, as well as the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands. Named the Analytical Laboratory System -... MORE

Members of the CBRN Defense community sit down during a presentation to celebrate the Analytical Laboratory System - Modification Work Order's achievement of full operational capacity

Batts Formally Recognized as the Defense Department’s Joint Project Manager for CBRN Protection
January 30, 2023 — Steven G. Batts, with over 38 years of service in the Defense Department and on active duty, formally assumed the charter on 20 December 2022 as the Joint Project Manager for Chemical, Biological, Radiological and Nuclear Protection (JPM CBRN Protection). In this role, Batts is responsible for the development, fielding, and modernization of... MORE

Steven G. Batts holds assumption of charter while shaking hands with Darryl J. Colvin

Senior Response Leaders Shown Latest Chemical, Biological Defense Technology Available for Disaster Response
December 22, 2022 — A group of senior leaders responsible for carrying out national disasters responses were recently shown the latest capabilities for responding to chemical, biological, radiological and nuclear (CBRN) events. On November 30, personnel from the Joint Program Executive Office for CBRN Defense along with the Air Force CBRN Defense Systems Branch and the Uniformed Services University’s 4DBio Program demonstrated current and future CBRN defense capabilities to a senior leadership team comprised of representatives from the White House’s Office of Science and Technology Policy, the National Security Council’s Office for Resilience and Response, the Defense Threat Reduction Agency, the Federal Emergency Management Agency (FEMA), and additional domestic emergency response organizations... MORE

Senior response leaders learn about the joint expeditionary collective protection family of systems available in the event of chemical or biological event

DoD Funds Production of More Life-Saving Medicine for Use After Nerve Agent Exposure
December 22, 2022 — The Defense Department's office responsible for acquiring medical countermeasures against chemical, biological, radiological and nuclear (CBRN) threats has awarded an agreement for the production of more life-saving nerve agent exposure treatments. The Joint Project Manager for CBRN Medical (JPM CBRN Medical) awarded a follow-on other transaction authority production agreement to Rafa Laboratories, Ltd. (Rafa) to manufacture and deliver 10mg midazolam injection autoinjectors to the Joint Force beginning December 2022. The midazolam injection autoinjector is indicated to treat prolonged seizures in adults, which can occur after exposure to a nerve agent. This new Advanced Anticonvulsant System (AAS) improves upon, and will eventually replace, the currently fielded Convulsant Antidote for Nerve Agent (CANA) diazepam autoinjector. Fielding the midazolam injection autoinjector gives the warfighter and the Nation access to a life-saving medical countermeasure in CBRN environments... MORE

3d CR Troopers test new protection garments
December 14, 2022 — 3d Cavalry Regiment Troopers took part in testing new Chemical, Biological, Radiation, and Nuclear protection garments here Dec. 5-8. The Chemical, Biological Duty Uniform (CBDU), is still in the testing phase but is projected to replace the Joint Service Lightweight Integrated Suit Technology (JSLIST) and fielded in the next few years. Features of the new CBDU improve on the fitting, comfort, weight, temperature regulation, and CBRN protection – much needed upgrades from the JSLIST Troopers are currently fielded, according to Tiffany Swidrak, a test support analyst for the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense – General Purpose team... MORE

A U.S. Army Trooper assigned to 3d Cavalry Regiment assumes a kneeling position with a dummy rifle while testing newly designed chemical, biological, radiation, and nuclear protection equipment Dec. 8, 2022, at Fort Hood, Texas. (U.S. Army photo by Staff Sgt. Christopher Stewart)

NSWC Crane employee serves public health overseeing $900M portfolio as U.S. expands vaccine and therapeutic manufacturing supply chain
December 14, 2022 — A Naval Surface Warfare Center, Crane Division (NSWC Crane) employee is serving on a detail overseeing a $900 million portfolio to expand the U.S. vaccine and therapeutic manufacturing supply chain. Over the past two years, these investments and partnerships with industry have developed into the construction of new manufacturing facilities across the country to develop future vaccine and therapeutic capabilities. The JPEO-CBRND and the Army Contracting Command were leveraged to assist the Biomedical Advanced Research and Development Authority, which is an office in the U.S. Department of Health and Human Services, who were tasked in 2020 to ensure that every COVID-19 vaccine, therapeutic, and test kit were bought, packaged, and delivered to the Nation. The JPEO-CBRND has a special Joint Assisted Acquisition (JA2) team, established by the May 2021 memorandum of understanding between DoD and HHS, which supports the continued contracting and acquisition expertise needed for the Nation’s ongoing mission to fight the coronavirus, including partnerships with the Federal COVID-19 Response interagency team, academia and the American industrial base... MORE

Naval Surface Warfare Center, Crane Division - Heather Baladi, NSWC Crane

Joint Teams Conduct First F-22 In-Flight Tests for Aircrew CBRN Protection
November 3, 2022 — The U.S. Air Force conducted the first in-flight vapor purge tests on the F-22 Raptor with the support of the 422nd Test and Evaluation Squadron and the 59th Test Squadron on Nellis Air Force Base from Oct. 13-21, 2022... MORE

U.S. and Israeli Collaboration at 20th Shoresh Meeting Promotes Advancement of CBRN Medical Countermeasure Development
October 20, 2022 — This past September, representatives from the U.S. Defense Department (DoD) participated in the 20th biennial Shoresh Military Medicine Conference in Rockville, Maryland. Shoresh, co-hosted by the Israeli Defense Force (IDF) and the U.S. Army Medical Research and Development Command (USAMRDC), is a collaborative gathering of DoD and IDF medical personnel that covers medical, chemical, biological defense, and military medicine topics. “You all save lives,” said Dr. Brian Lein, the Defense Health Agency’s assistant director for healthcare administration. “The things we talked about four or six years ago are now saving American and Israeli lives, based on innovation first developed here.”... MORE

Brig. Gen. Anthony McQueen, commanding general of U.S. Army's Medical Research and Development Command (MRDC), speaks during a panel presentation at the 20th biennial Shoresh Military Medicine Conference in Rockville, Maryland, Sept. 19, 2022.

News Search

News Archive - Search by Year and Month

April 2024 (1)
March 2024 (3)
February 2024 (3)
January 2024 (2)
December 2023 (2)
November 2023 (2)
October 2023 (5)
September 2023 (6)
August 2023 (8)
July 2023 (2)
June 2023 (2)
May 2023 (3)
April 2023 (2)
March 2023 (1)
February 2023 (1)
January 2023 (1)
December 2022 (4)
November 2022 (1)
October 2022 (3)
September 2022 (5)
August 2022 (3)
July 2022 (3)
June 2022 (1)
May 2022 (1)
March 2022 (2)
February 2022 (2)
January 2022 (5)
December 2021 (1)
November 2021 (6)
October 2021 (2)
September 2021 (1)
July 2021 (1)
June 2021 (1)
May 2021 (8)
April 2021 (6)
March 2021 (2)
February 2021 (5)
January 2021 (4)
December 2020 (3)
November 2020 (1)
August 2020 (1)
July 2020 (3)
May 2020 (1)
April 2020 (1)
March 2020 (4)
February 2020 (1)
December 2019 (2)
November 2019 (2)
October 2019 (2)
September 2019 (2)
March 2019 (1)
January 2019 (2)
December 2018 (1)
October 2018 (1)
July 2018 (1)
April 2018 (1)
February 2018 (1)
December 2017 (1)
November 2017 (2)
September 2017 (1)
June 2017 (2)
January 2017 (3)
December 2016 (1)

JPEO-CBRND Press Kit

Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.

JPEO-CBRND Public Affairs Office

The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.